Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Supporting your high street Find out how »
FDA Review of Drug Applications, PDF eBook

FDA Review of Drug Applications PDF

Edited by Morris Cooperman, Richard J. Porter

PDF

Download - Immediately Available
Please note: eBooks can only be purchased with a UK issued credit card and all our eBooks (ePub and PDF) are DRM protected.

Description

In the late 1980s, the median time for FDA to approve a new drug application (NDA) was 29 months.

Industry, consumer groups, and FDA agreed that the time from submission of a drug or biologics application to FDA's decision was unacceptably long.

Patient advocates argued that a drug in review--and therefore not available for sale--could be the difference between life and death.

Manufacturers argued that prolonged review times affected their ability to recoup the costs of research and development.

This book examines the FDA's review of drug applications, with a focus on the Prescription Drug User Fee Act (PDUFA) and issues for reauthorization in 2012.

Information

Save 15%

£95.00

£80.75

Download - Immediately Available
Add to Basket
Sign in to add to wishlist
 
Delivered to your inbox

to transfer to your device

eBook Help

Is this the right eBook for
my device? How do I download
this eBook? See help and FAQs pages

Information